Answered and open questions from 7 years... | American Society of Hematology

$Answered and open questions from 7 years of the MURANO trial. CIT, chemoimmunotherapy; BCL2i, BCL2 inhibitor; BTKi, BTK inhibitor; r/r, relapsed/refractory.$

Answered and open questions from 7 years of the MURANO trial. CIT, chemoimmunotherapy; BCL2i, BCL2 inhibitor; BTKi, BTK inhibitor; r/r, relapsed/refractory.

This Feature Is Available To Subscribers Only